生物活性 靶点 体外研究 体内研究
ChemicalBook  CAS数据库列表  145841-10-7

145841-10-7

145841-10-7,145841-10-7,结构式
145841-10-7
  • CAS号:145841-10-7
  • 英文名:Sch-42495 (racemate)
  • 中文名:145841-10-7
  • CBNumber:CB33175586
  • 分子式:C20H29NO4S2
  • 分子量:411.58
  • MOL File:145841-10-7.mol
145841-10-7化学性质
  • 沸点 :597.3±50.0 °C(Predicted)
  • 密度 :1.158±0.06 g/cm3(Predicted)
  • 储存条件 :Store at -20°C
  • 溶解度 :Soluble in DMSO
  • 酸度系数(pKa) :13.50±0.46(Predicted)

145841-10-7性质、用途与生产工艺

  • 生物活性 SCH 42495 racemate 是 Sch-42495 的外消旋体。SCH 42495 是一种具有口服活性的中性金属内肽酶 (NEP) 抑制剂,具有抗高血压活性。SCH 42495 是 SCH 42354 的口服活性前药。
  • 靶点

    NEP

  • 体外研究

    SCH 42495 selectively inhibits hydrolysis of leu-enkephalin and ANF (IC 50 of 8.3 and 10.0 nM, respectively) in vitro.

  • 体内研究

    SCH 42495 (30 mg/kg; oral gavage; twice daily) causes a significant reduction in the pulmonary vascular remodelling and ventricular hypertrophy in hypoxic rats after 10 days.
    Treatment with SCH 42495 (30 mg/kg; oral gavage; twice daily) leads to a decrease in cardiovascular remodelling secondary to chronic hypoxia in rats.
    SCH 42495 (oral doses of 1, 3, or 10 mg/kg) produces significant reductions in blood pressure in DOCA-N a hypertensive rats of 22±6, 43±7, and 62±12 mm Hg, respectively.

    Animal Model: Hypoxic rats
    Dosage: 30 mg/kg
    Administration: Oral gavage; twice daily for 10 days
    Result: Caused a significant reduction in the pulmonary vascular remodelling and ventricular hypertrophy.
    Led to a decrease in cardiovascular remodelling secondary to chronic hypoxia.
145841-10-7上下游产品信息
上游原料
下游产品
145841-10-7生产厂家
  • 公司名称:TargetMol中国(陶术生物)
  • 联系电话: 4008200310
  • 电子邮件:marketing@tsbiochem.com
  • 国家:中国
  • 产品数:21667
  • 优势度:58